Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 7Recruiting 4Unknown 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2CNS 1

Conditions

Neoplasms 4Venous Thrombosis 2Venous Thromboembolism 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Thrombosis 1Thromboembolism 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Lung Neoplasms 1Inflammation 1Immune System Diseases 1Glioma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Dyskinesias 1Duodenal Neoplasms 1Cholangiocarcinoma 1Cardiovascular Diseases 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Rivaroxaban 2Tinzaparin 1Surveys and Questionnaires 1Long-Term Synaptic Depression 1Heparin, Low-Molecular-Weight 1Enoxaparin 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Venous Thromboembolism × Rivaroxaban × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

NCT04999176 2021-08-10

VALERIA

Science Valley Research Institute

Phase 3 Unknown
440 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡